Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.3128 +0.0028 (+0.90%)
Streaming Delayed Price Updated: 9:52 AM EDT, Aug 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now
Via AB Newswire
Topics Artificial Intelligence
News headline image
MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now
Via AB Newswire
Topics Artificial Intelligence
News headline image
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum
Via AB Newswire
Topics Animal Testing Artificial Intelligence
News headline image
IGC Pharma Reports Q2 2026 Results as CALMA Alzheimer's Trial Moves Within Six Randomizations of Enrollment Closure
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
VivoSim Labs (NASDAQ: VIVS) Emerges in Drug Toxicity Market as Revenue Growth Guidance Tops 500% – Plus More In Focus
Via AB Newswire
Topics Animal Testing Artificial Intelligence
News headline image
Kartoon Studios (NYSE: TOON) Enters Next Growth Phase; Reports Q2 Revenue of $5.82M, EPS of $0.38 and $40.5M Cash Position – Plus More in Focus
Via AB Newswire
Topics Intellectual Property
News headline image
Kartoon Studios (NYSE: TOON) Signs Amazon Prime Deal for “Hundred Acre Wood” Streaming Launch
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to Watch – Plus More in Focus
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline Readout
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results
From New to The Street
Via ACCESS Newswire
News headline image
Bullish Volume: RITR, IGC, BJDX, CISS Lead Active Sub-$1 Stocks to Watch
Via AB Newswire
Topics Artificial Intelligence Economy Fraud
News headline image
Microcaps MGRX, PRSO, IGC, KUST In the News to Watch
Via AB Newswire
Topics Artificial Intelligence Energy Fraud
News headline image
IGC Pharma Evaluates Potential Recovery Options as Federal Jury Verdict Brings Renewed Attention to 2018 IGC Short Campaign
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
Undervalued Stocks in Focus: IGC, CISS, TOON, GOSS, KIDZ Enter Catalyst-Rich Growth Phase
Via AB Newswire
Topics Artificial Intelligence
News headline image
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)
From New to The Street
Via ACCESS Newswire
News headline image
IGC Pharma (NYSE: IGC) Showcasing 7 AI Breakthroughs Advancing Alzheimer’s Drug Discovery at AAIC 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
IGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer’s Drug Development and Key 2026 Catalysts on The Street Podcast
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares
Via AB Newswire
Topics Artificial Intelligence
News headline image
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) CEO Discusses Commercial Graphene Growth and Global Expansion Watch Now!
Via AB Newswire
Topics Artificial Intelligence
News headline image
Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates
Via AB Newswire
Topics Artificial Intelligence
News headline image
MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma’s (NYSE American: IGC) AI Platform Cuts Alzheimer’s Research by 90%, Accelerating Drug Discovery
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow
From IGC Pharma, Inc.
Via ACCESS Newswire
News headline image
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
From New to The Street
Via ACCESS Newswire
News headline image
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
Via ACCESS Newswire
News headline image
IGC Pharma (NYSE American: IGC) Alzheimer’s Drug Gains Attention After Ascendiant Capital Raises Price Target
Via AB Newswire
Topics Artificial Intelligence
News headline image
IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.